Anixa Biosciences
ANIX
66 hedge funds and large institutions have $17.6M invested in Anixa Biosciences in 2025 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 3 closing their positions.
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
56% more call options, than puts
Call options by funds: $67K | Put options by funds: $43K
14% more funds holding
Funds holding: 58 → 66 (+8)
10% more capital invested
Capital invested by funds: $16M → $17.6M (+$1.62M)
0.8% less ownership
Funds ownership: 17.41% → 16.61% (-0.8%)
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$203K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$71.4K |
| 3 |
BFS
Bradley Foster & Sargent
Hartford,
Connecticut
|
+$57.9K |
| 4 |
LPL Financial
San Diego,
California
|
+$52.1K |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$41.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$510K |
| 2 |
MWM
Mission Wealth Management
Santa Barbara,
California
|
-$286K |
| 3 |
Focus Partners Wealth
Boston,
Massachusetts
|
-$153K |
| 4 |
BlackRock
New York
|
-$103K |
| 5 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$82.9K |
ANIX Hedge Fund Activity: Q2 2025 in Review
66 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q2 2025, worth a combined $17.6M — up 10% from $16M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ANIX positions and 3 closed out — a net gain of 9 holders — while 11 added to existing stakes and 12 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $203K. The largest seller was Susquehanna International Group, cutting an estimated $510K.
- 66 institutional investors held Anixa Biosciences (ANIX) as of Q2 2025, up from 58 in Q1 2025.
- Funds reported $17.6M of Anixa Biosciences stock for Q2 2025, up 10% quarter-over-quarter.
- 12 funds opened new Anixa Biosciences positions in Q2 2025 and 3 closed out, a net change of +9 holders.
- The largest Anixa Biosciences buyer in Q2 2025 was Citadel Advisors, an estimated $203K added.
- The largest Anixa Biosciences seller in Q2 2025 was Susquehanna International Group, an estimated $510K sold.
Based on aggregated 13F filings for Q2 2025.